Halpern Financial’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$5.72K Hold
200
﹤0.01% 179
2024
Q2
$5.6K Hold
200
﹤0.01% 175
2024
Q1
$5.44K Hold
200
﹤0.01% 178
2023
Q4
$5.95K Hold
200
﹤0.01% 198
2023
Q3
$6.63K Hold
200
﹤0.01% 172
2023
Q2
$7.34K Hold
200
﹤0.01% 185
2023
Q1
$8.16K Hold
200
﹤0.01% 135
2022
Q4
$10.2K Sell
200
-189
-49% -$9.06K ﹤0.01% 135
2022
Q3
$17K Sell
389
-188
-33% -$9.13K 0.01% 120
2022
Q2
$30.3K Buy
577
+188
+48% +$9.58K 0.01% 100
2022
Q1
$20.1K Hold
389
0.01% 141
2021
Q4
$23K Hold
389
0.01% 127
2021
Q3
$16.7K Hold
389
0.01% 135
2021
Q2
$15.2K Hold
389
0.01% 126
2021
Q1
$14.1K Hold
389
0.01% 118
2020
Q4
$14.3K Sell
389
-21
-5% -$770 0.01% 100
2020
Q3
$14.3K Hold
410
0.01% 91
2020
Q2
$12.7K Hold
410
0.01% 85
2020
Q1
$12.7K Hold
410
0.01% 75
2019
Q4
$15.2K Buy
+410
New +$14.6K 0.01% 94

Other funds holding PFE

Halpern Financial's PFE Position: Q3 2024 in Review

Halpern Financial held its Pfizer (PFE) position steady in Q3 2024 at 200 shares worth $5.72K. The position accounts for ﹤0.01% of the portfolio, ranked #179.

Halpern Financial first reported a position in PFE in Q4 2019 and has held it in 20 quarters since. The position peaked at $30.3K in Q2 2022. 2,910 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • Halpern Financial held 200 shares of Pfizer worth $5.72K as of Q3 2024.
  • Halpern Financial left its Pfizer share count unchanged in Q3 2024.
  • Pfizer made up ﹤0.01% of Halpern Financial's portfolio in Q3 2024, its #179 holding.
  • Halpern Financial first reported a position in Pfizer in Q4 2019 and has held it in 20 quarters since.
  • Halpern Financial's Pfizer position peaked at $30.3K in Q2 2022.
  • 2,910 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Halpern Financial's 13F filing for Q3 2024, filed 4 Oct 2024.